A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter] [0.03%]
携带MAP2K1致病变异的卡尼奥-费阿-皮肤综合征病例报告
Abdul Hadi Furqoni,Indah Fajarwati,Anna Lystia Poetranto
Abdul Hadi Furqoni
Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans [0.03%]
动脉硬化闭塞症 circular RNA 表达谱及 bioinformatics 分析
Yu Zhou,Huoying Cai,Lin Huang et al.
Yu Zhou et al.
Background: Arteriosclerosis obliterans (ASO) is the leading cause of nontraumatic lower-extremity amputations. Multiple researches have suggested that circular RNAs (circRNAs) played vital regulatory functions in cancer ...
Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes [0.03%]
CYP450酶和ABCB1多态性对急性冠脉综合征患者氯吡格雷反应的影响：一项关于摩洛哥人的研究
Ismail Mouhrach,Laila Bouguenouch,Adil Kamal et al.
Ismail Mouhrach et al.
Introduction: Clopidogrel is an antiplatelet prodrug primarily prescribed to prevent or treat acute coronary syndrome (ACS) or acute ischemic stroke (IS), polymorphisms of genes encoding cytochrome P-450 (CYP) and P-glyco...
Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack [0.03%]
同型半胱氨酸降低以预防卒中——关于AHA/ASA卒中和短暂性脑缺血发作的预防指南（2021）的一点思考
Craig Brown,Jianhua Wang,Hong Jiang et al.
Craig Brown et al.
Reduction of secondary ischemic stroke risk following an initial stroke is an important goal. The 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack assembles opportunities for up to 80% secondary stroke reducti...
Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies [0.03%]
印度 cardiomyopathy 患者中MYBPC3的新突变
Deepa Selvi Rani,Apoorva Kasala,Perundurai S Dhandapany et al.
Deepa Selvi Rani et al.
Background: Mutations in Myosin Binding Protein C (MYBPC3) are one of the most frequent causes of cardiomyopathies in the world, but not much data are available in India. ...
Genome-Wide Identification of lncRNA and mRNA for Diagnosing Type 2 Diabetes in Saudi Arabia [0.03%]
用于在沙特阿拉伯诊断2型糖尿病的长链非编码RNA和mRNA的全基因组识别
Sarah Albogami
Sarah Albogami
Purpose: According to the World Health Organization, Saudi Arabia ranks seventh worldwide in the number of patients with diabetes mellitus. To our knowledge, no research has addressed the potential of noncoding RNA as a d...
Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation [0.03%]
NAT2基因多态性在2型糖尿病及脂质代谢中的临床意义
Yazun Jarrar,Sara Abudahab,Ghasaq Abdul-Wahab et al.
Yazun Jarrar et al.
Background: N-acetyltransferase 2 (NAT2) enzyme is a Phase II drug-metabolizing enzyme that metabolizes different compounds. Genetic variations in NAT2 can influence the enzyme's activity and potentially lead to the devel...
Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer [0.03%]
染色体拷贝数变异预测非小细胞肺癌患者EGFR-TKI的疗效和预后
Haiyan He,Hang Ma,Zhuo Chen et al.
Haiyan He et al.
Purpose: Chromosomal abnormalities represent genomic signatures linked to cancer prognosis and responses to chemotherapy, immunotherapy, and drug resistance. This study aimed to investigate the impact of chromosome copy n...
Genetic Polymorphism of NQO1 Influences Susceptibility to Coronary Heart Disease in a Chinese Population: A Cross-Sectional Study and Meta-Anaylsis [0.03%]
NQO1基因多态性对中国人群冠心病易感性的影响：一项横断面研究和荟萃分析
Ying-Yan Zhou,Jing-Hua Sun,Li Wang et al.
Ying-Yan Zhou et al.
Objective: The present study is to explore the association between NQO1 gene polymorphism and coronary heart disease (CHD) risk. Methods: ...
A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [0.03%]
携带MAP2K1致病突变的心颜皮肤综合征病例报告
Qiong Tang,Dai Gong,Xiao-Min Ye et al.
Qiong Tang et al.
Craniofacial dysmorphism, cardiac abnormalities, ectodermal abnormalities, psychomotor delay, intellectual disability, and short stature are all hallmarks of the extremely rare disorder known as cardiofaciocutaneous syndrome (CFCS). Althoug...